Finance

Lists
4553:TYO
Towa Pharmaceutical Co Ltd
3 610,00 JPY
+1,69%
(+60,00) 1D
15 სექ, 10:02:20 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4553...
Open
3 570 JPY
High
3 610 JPY
Low
3 570 JPY
Mkt. cap
185,97 მლრ.
Avg. vol.
112,69 ათ.
Volume
21,20 ათ.
Dividend
2,22%
Quarterly dividend
20 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
21,49
52-wk high
4 490 JPY
52-wk low
2 764 JPY
EPS
168 JPY
Shares outstanding
16,40 მლნ.
No. of employees
5 ათ.
Open
3 570 JPY
High
3 610 JPY
Low
3 570 JPY
Mkt. cap
185,97 მლრ.
Avg. vol.
112,69 ათ.
Volume
21,20 ათ.
Dividend
2,22%
Quarterly dividend
20 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
21,49
52-wk high
4 490 JPY
52-wk low
2 764 JPY
EPS
168 JPY
Shares outstanding
16,40 მლნ.
No. of employees
5 ათ.
About Towa Pharmaceutical Co Ltd
CEO-
Employees4,92 ათ.
Founded1951
Headquarters-
SectorPharmaceutical industry
Websitetowayakuhin.co.jp
Last report
6 აგვ. 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
71,38 მლრდ. / 72,26 მლრდ.
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
65,33 მლრდ.
73,59 მლრდ.
69,64 მლრდ.
71,38 მლრდ.
Cost of goods sold
41,80 მლრდ.
45,67 მლრდ.
45,66 მლრდ.
45,28 მლრდ.
Cost of revenue
41,80 მლრდ.
45,67 მლრდ.
45,66 მლრდ.
45,28 მლრდ.
Research and development expenses
-
-
17,94 მლრდ.
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,29 მლრდ.
18,87 მლრდ.
2,42 მლრდ.
19,58 მლრდ.
Operating expense
18,29 მლრდ.
18,87 მლრდ.
20,37 მლრდ.
19,58 მლრდ.
Total operating expenses
60,09 მლრდ.
64,54 მლრდ.
66,03 მლრდ.
64,86 მლრდ.
Operating income
5,24 მლრდ.
9,05 მლრდ.
3,61 მლრდ.
6,52 მლრდ.
Other non operating income
1,50 მლრდ.
3,31 მლრდ.
-4,49 მლრდ.
1,83 მლრდ.
EBT including unusual items
8,00 მლრდ.
12,00 მლრდ.
-10,79 მლრდ.
7,94 მლრდ.
EBT excluding unusual items
6,47 მლრდ.
12,01 მლრდ.
-1,29 მლრდ.
8,14 მლრდ.
Income tax expense
2,29 მლრდ.
3,13 მლრდ.
1,05 მლრდ.
2,41 მლრდ.
Effective tax rate
28,69%
26,07%
-9,70%
30,37%
Other operating expenses
-
-
-
-
Net income
5,70 მლრდ.
8,87 მლრდ.
-11,83 მლრდ.
5,53 მლრდ.
Net profit margin
8,73%
12,05%
-16,99%
7,75%
Earnings per share
-
-
-
-
Interest and investment income
93,00 მლნ.
76,00 მლნ.
89,00 მლნ.
75,00 მლნ.
Interest expense
-609,00 მლნ.
-532,00 მლნ.
-580,00 მლნ.
-628,00 მლნ.
Net interest expenses
-516,00 მლნ.
-456,00 მლნ.
-491,00 მლნ.
-553,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
10,89 მლრდ.
14,93 მლრდ.
9,66 მლრდ.
11,58 მლრდ.
Gain or loss from assets sale
32,00 მლნ.
14,00 მლნ.
14,80 მლრდ.
-2,00 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები